SMAD4 and pancreatic neoplasm: The most common blood-based biomarker studies in pancreatic cancer include the analysis of circulating mutations in cfDNA, and the mutated genes most frequently detected are KRAS, TP53, APC, SMAD4 or FBXW7 [34].